Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors

Clinical trial NCT03878095 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03878095
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Solid Neoplasm Refractory Cholangiocarcinoma Refractory Malignant Solid Neoplasm

Start date: 2020-01-30
Primary completion: 2025-03-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.